In Vitro and In Silico Studies on Cytotoxic Properties of Oxythiamine and 2'-Methylthiamine

Marta Malinowska1, Magdalena Czerniecka2,3, Izabella Jastrzebska1

  • 1Faculty of Chemistry, University of Bialystok, Ciolkowskiego 1K, 15-245 Bialystok, Poland.

Insights

2'-methylthiamine shows potential as a cytostatic compound against cancer cells. While oxythiamine is more effective at inhibiting cancer cell growth, 2'-methylthiamine exhibits greater selectivity for cancer cells and a stronger affinity for thiamine pyrophosphokinase.

Area of Science:

  • Biochemistry
  • Cancer Research
  • Pharmacology

Background:

  • Cytostatic compounds are crucial for cancer treatment.
  • 2 -methylthiamine, a thiamine antimetabolite, has not been previously investigated for its cytostatic potential.
  • Thiamine pyrophosphokinase is a key enzyme in thiamine metabolism.

Purpose of the Study:

  • To synthesize 2 -methylthiamine using a simplified method.
  • To compare the in vitro effects of 2 -methylthiamine and oxythiamine on normal fibroblasts and HeLa cancer cells.
  • To investigate the potential of 2 -methylthiamine as a cytostatic agent.

Main Methods:

  • In vitro cell culture techniques using normal skin fibroblasts and HeLa cancer cells.
  • Growth inhibition (GI50) and selectivity index (SI) assays.
  • Molecular docking analyses to assess binding affinity with thiamine pyrophosphokinase.

Main Results:

  • Oxythiamine significantly inhibited cancer cell growth and metabolism (GI50 = 36 µM) compared to 2 -methylthiamine (GI50 = 107 µM).
  • 2 -methylthiamine demonstrated higher selectivity for cancer cells (SI = 180) than oxythiamine (SI = 153).
  • Docking analysis revealed 2 -methylthiamine has a higher binding affinity to thiamine pyrophosphokinase (ΔG = -8.2 kcal/mol) than thiamine and oxythiamine.

Conclusions:

  • 2 -methylthiamine is a potential cytostatic agent due to its selectivity and affinity for thiamine pyrophosphokinase.
  • Limited cellular uptake may hinder the efficacy of 2 -methylthiamine.
  • Further research is needed to optimize 2 -methylthiamine delivery for enhanced cytostatic effects.